Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder
Frontiers in Public Health · 23.04.2026 · 14
DOI: 10.3389/fpubh.2026.1773558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 23.04.2026. Verfasst von Lea Kozina und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Psychiatric Hospital Vrapče, Zagreb, Croatia. Hauptthemen laut MEDLINE: Alcoholism, COVID-19. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Patients with alcohol use disorder (AUD) are at higher risk for long-term Coronavirus Disease 2019 (COVID-19) related consequences, due to bidirectional relationship and shared biological pathways between chronic alcohol use and COVID-19 disease. However, they are significantly underrepresented in the literature examining adverse outcomes associated with COVID-19 disease.
Objective
Therefore, we comprehensively examined the initial group differences between AUD patients who experienced symptomatic COVID-19 disease and AUD patients without a history of COVID-19 disease. We investigated differences between COVID-19 and non-COVID-19 groups in AUD severity (alcohol use, alcohol craving), cognitive functions (assessed by the Montreal Cognitive Assessment), and basic blood parameters.
Methods
This pilot study was conducted in two study points 6 months apart. Participants were 32 COVID-19 AUD patients and 31 non-COVID-19 AUD patients, who met rigorous inclusion and exclusion criteria. Sociodemographic questionnaire, COVID-19 interview and validated measurement instruments (5.0.0. Mini International Neuropsychiatric Interview, M.I.N.I.; Penn Alcohol Craving Scale, PACS; Alcohol Use Disorders Identification Test, AUDIT; Montreal Cognitive Assessment, MoCA; Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised, CIWA-Ar) were assessed. Also, blood parameters were measured: erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as inflammatory; alanine transaminase (ALT), aspartate transaminase (AST) and gamma-glutamyl transferase (GGT) as biochemical; total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TG) as lipid parameters.
Results
In the COVID-19 group, 93.7 % of participants had a mild form of the disease. There was significant difference between the two groups in cognitive functions which improved in the non-COVID-19 group, whereas they remained unchanged in the COVID-19 group [ F (1, 56.157) = 6.875, p = 0.011]. TC showed distinct pattern over time in the COVID-19 group [ F (1, 49.997) = 18.234, p = < 0.001]. CRP showed a weak negative relationship with the time since recovery from COVID-19 ( b = −0.025, p = 0.009). The non-relapse group also showed an improvement in cognitive functions after six months, in contrast to the relapse group [ F (1, 56.157) = 6.879, p = 0.011]. In all participants, HDL levels increased after six months [ F (1, 58.036) = 4.604, p = 0.036].
Conclusions
Cognitive functions and blood parameters require long-term follow-up in COVID-19 AUD patients. Better clinical and blood outcomes in non-relapse group support the overall benefits of reduction in alcohol use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Psychiatric Hospital Vrapče, Zagreb, Croatia.
- The Institute of Social Sciences Ivo Pilar, Zagreb, Croatia.
- School of Medicine, University of Zagreb, Zagreb, Croatia.
Zitieren
APA
Kozina, L., Blažev, D., Zakić-Milas, D., & Kovačić Petrović, Z. (2026). Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1773558
Vancouver
Kozina L, Blažev D, Zakić-Milas D, Kovačić Petrović Z. Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1773558
BibTeX
@article{Kozina2026,
author = {Kozina, Lea and Blažev, Divna and Zakić-Milas, Danijela and Kovačić Petrović, Zrnka},
title = {Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1773558}
}
EUVIMED